Marlene B. Goldman, M.S., Sc.D.
Professor of Obstetrics and Gynecology
Community and Family Medicine
Director of Clinical Research
Obstetrics and Gynecology
1970 A.B. Colby College, Waterville, ME
1978 M.S. Harvard University, School of Public Health, Boston, MA
1984 Sc.D. Harvard University, School of Public Health, Boston, MA
Norris Cotton Cancer Center
Department of Obstetrics and Gynecology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
Office: Faulkner, 5M
Asst. Phone: 603-653-3968
Dr. Goldman is a reproductive epidemiologist and Director of Clinical Research in the Department of Obstetrics and Gynecology. She specializes in research and teaching related to women's health. Her research program includes several large randomized clinical trials evaluating optimal infertility treatment for younger and older women seeking to conceive and a prospective cohort study investigating the role of preconception nutrition and oxidative stress on implantation and early pregnancy loss. She is senior editor of Women & Health, a comprehensive reference textbook for researchers, teaching faculty, and clinicians now in its second edition.
2006-2013 Principal Investigator, R01 HD049762, Antioxidant Status, Diet, and Early Pregnancy. NICHD/NIH, $3,171,000.
2009-2011 Principal Investigator, R01 HD049762S1, Antioxidant Status, Diet, and Early Pregnancy, NICHD/NIH, $264,944.
2009-2011, Co-investigator, R21 HD060829, Development of an Infertility Family Registry, NICHD/NIH, PI: Stern.
2009-2011, Co-investigator, R03 HD061867, Decision-making in Pelvic Floor Disorders: Translating Outcomes to Practice, NICHD/NIH, PI: Whiteside.
2003-2011 Co-Investigator, R01 HD44457, Optimal Infertility Therapy RCT: Women 40 and Older. NICHD/NIH, PI: Reindollar, R., $3,195,000.
2000-2008 Co-Investigator, R01 HD38561, Conventional Infertility Therapy vs. Fast Track to IVF. NICHD/NIH, PI: Reindollar, R., $2,720,000.
2003-2006 Principal Investigator, UC1 HS014376, Risk and Recovery in Complex Environments: Labor & Delivery as a Model. AHRQ, $200,000.
Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Human Reproduction Update 2008;14:345-357. (view details on MedLine)
Stern JE, Goldman MB, Hatasaka H, Mackenzie TA, Surrey ES, Racowsky C. Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study. Fertil Steril 2009;91:767-776. (view details on MedLine)
Ruder EH, Hartman TJ, Goldman MB. Impact of oxidative stress on female fertility. Curr Opin Obstet Gynecol 2009;21:219-222 (view details on MedLine)
Stern JE, Goldman MB, Hatasaka H, Mackenzie TA, Racowsky C, Surrey ES. Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study. Fertil Steril 2009;91;157-166. (view details on MedLine)
Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010;94:888-899. (view details on MedLine)
Reindollar RH, Goldman MB. Gonadotropin therapy: a 20th century relic. Fertil Steril 2012;97:813-818. (view details on MedLine)
Paine MA, Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress, oogenesis and folliculogenesis. Oxidative Stress and Women's Health (Agarwal, Rizk, Aziz, eds.), Springer, 2013.
Goldman MB, Troisi R, Rexrode KM (eds). Women & Health (2nd edition). 2013. http://booksite.elsevier.com/9780123849786